Artificial Intelligence Based Timing, Infarct Size and Outcomes in Acute Coronary Occlusion Myocardial Infarction
ANOMI
1 other identifier
observational
1,500
1 country
1
Brief Summary
The present study is practice-driven and merely observational and prospective. In clinical routine, patients who suffer from suspected ACS and do not show ST elevation in the ECG, different timing proposals in the guidelines and logistically driven differences lead to considerably variable timings in invasive coronary anatomy assessments. This handling may lead to larger infarct sizes when OMI is overseen. Therefore, the present study aims to observe a) whether an AI model is capable of correctly identify OMI in eligible patients and b) if in these patients troponin peak levels vary depending on the elapsed time between OMI diagnosis and coronary intervention. As the model has not been established yet clinically and in the guidelines, it is safe to assume the usual pathway from first medical contact to specialist's attention is undertaken. When a patient presents in an emergency department or places an emergency call, the physicians assess the situation as usal and as stated in the current guidelines1. If no STEMI is confirmed, the NSTE-ACS protocol is started. The patients who are ruled out for ACS are excluded from the final analysis (screening). In this case, the AI model is tested on their ECG in order to assess whether there are false positives. The patients which are in the ACS "rule-in" trail and undergo final coronary angiography will naturally be divided in patients which were classified as OMI and as non-OMI by the AI model. Furthermore, they will present a different "Time from OMI diagnosis to PCI) and variable troponin peak levels. By leveraging this natural variability, a practical distinction and multiple analyses can be done:
- 1.The feasibility of AI-powered ECG interpretation in the care of patients with suspected ACS and without clear ST-elevation infarction
- 2.The accuracy of AI-powered ECG interpretation in detecting OMI compared to the classical STEMI criteria
- 3.How infarct size correlates with different ECG readings by AI and (hypothesis generating) if changing the clinical practice could lead to a benefit in patients with suspected OMI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 28, 2025
CompletedFirst Posted
Study publicly available on registry
April 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
April 21, 2026
April 1, 2026
2.3 years
March 28, 2025
April 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cardiovascular Mortality
Cardiovascular Mortality
12 months
Infarct Size
Infarct size measured by transthoracic echocardiogram or cardiac magnetic resonance imaging
12 months
Other Outcomes (1)
Performance of AI-based OMI detection
Periprocedural (at the time of coronary angiography)
Study Arms (1)
NSTE-ACS
Patients with Non ST-Elevation myocardial infarction
Interventions
Diagnostic/therapeutic procedure to reopen an occluded coronary artery by inflating a balloon and inserting a stent
Eligibility Criteria
Patients presenting with chest pain and deemed as Non-ST Elevation Myocardial Infarction by the specialist, whether in the emergency medicine setting or in-hospital
You may qualify if:
- Age \> 18 yrs
- Working diagnosis of Non- ST Elevation Acute Coronary Syndrome after the assessment by specialist
You may not qualify if:
- ST-Elevation Myocardial infarction
- Age \< 18 yrs
- Major sustained ventricular arrhythmias
- Corrupted ECG images
- Poor digitalisation quality of the ECG
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azienda Sanitaria di Bolzano
Bolzano, BZ, 39100, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. Dr.med. Dr. Med.univ. Matthias Unterhuber
Study Record Dates
First Submitted
March 28, 2025
First Posted
April 4, 2025
Study Start
April 1, 2024
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
April 21, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
The trial is investigator initiated and patient privacy is of paramount importance.